AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue609,946532,091418,276
Cost of Revenue183,166116,88988,501
Gross Profit426,780415,202329,775
Operating Expenses
Research Development75,01766,08442,878
Selling General and Administrative259,933249,870160,309
Non Recurring385,09120,37815,368
Total Operating Expenses---
Operating Income or Loss-293,26178,870111,220
Income from Continuing Operations
Total Other Income/Expenses Net-8,4513,338-18,125
Earnings Before Interest and Taxes-301,71282,20893,095
Interest Expense68,38273,15353,251
Income Before Tax-370,0949,05539,844
Income Tax Expense-170,86611,5387,065
Minority Interest---
Net Income From Continuing Ops-199,228-2,48332,779
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-199,228-2,48332,779
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-199,228-2,48332,779